Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Clinical trial data do not apply: Eli Lilly's investigational Retatrutide has been studied in human clinical trials, and adverse event data from those trials are published [3]
Its important for your provider to review your medical history fully before making the switch to tirzepatide
[1] [2] Musculoskeletal side effects were not prominently highlighted as primary adverse outcomes in the published Phase 2 data
Do GLP-1 drugs help neuropathic pain in diabetes
Missed doses or changes in injection timing can affect how steadily the medication works, which may contribute to a plateau
Semaglutide might be better for you if You have type 2 diabetes (additional blood sugar benefits) You prefer a medication with longer clinical history You want proven, consistent results Insurance covers semaglutide but not tirzepatide Tirzepatide might be better for you if You want potentially greater weight loss Youve tried semaglutide without optimal results You have both weight and blood sugar concerns You can tolerate potentially higher initial costs Both medications work best for people who Have a BMI of 30 or higher (or 27+ with weight-related health conditions) Are committed to lifestyle changes Can handle weekly injections Want non-surgical weight loss treatment
